/Companies

Saghmos Therapeutics

Greenwich, US · Founded 2016 · Delaware corporation

Find your way into Saghmos Therapeutics

Sign up to see every warm intro you have to Saghmos Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Saghmos Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

AK
Anna KazanchyanNamed on SEC filing
SC
Shalini CornelioNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2017

▶$3.5MraisedApr 2018 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anna KazanchyanExecutive Officer
  • Shalini CornelioExecutive Officer
Offering amount
$7M
Amount sold
$3.5M
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Saghmos Therapeutics raised?
Saghmos Therapeutics has disclosed $3.5M raised across 1 round.
Where is Saghmos Therapeutics headquartered?
Saghmos Therapeutics is headquartered in Greenwich, US.